231 related articles for article (PubMed ID: 30711628)
1. Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.
Vijayvargiya P; Camilleri M; Chedid V; Mandawat A; Erwin PJ; Murad MH
Gastroenterology; 2019 May; 156(6):1650-1660. PubMed ID: 30711628
[TBL] [Abstract][Full Text] [Related]
2. Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence.
Goelen N; Jones M; Huang IH; Carbone F; Janssen P; Tack J
United European Gastroenterol J; 2023 Mar; 11(2):146-162. PubMed ID: 36714973
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
[TBL] [Abstract][Full Text] [Related]
4. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
6. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
Janssen P; Harris MS; Jones M; Masaoka T; Farré R; Törnblom H; Van Oudenhove L; Simrén M; Tack J
Am J Gastroenterol; 2013 Sep; 108(9):1382-91. PubMed ID: 24005344
[TBL] [Abstract][Full Text] [Related]
7. [Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].
Serra J
Gastroenterol Hepatol; 2010 Oct; 33(8):586-90. PubMed ID: 20850200
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying].
Portincasa P; Mearin F; Robert M; Plazas MJ; Mas M; Heras J
Gastroenterol Hepatol; 2009 Dec; 32(10):669-76. PubMed ID: 19819042
[TBL] [Abstract][Full Text] [Related]
9. Drugs acting at 5-HT4 , D2 , motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach.
Broad J; Góralczyk A; Mannur K; Dukes GE; Sanger GJ
Neurogastroenterol Motil; 2014 Jun; 26(6):851-61. PubMed ID: 24750304
[TBL] [Abstract][Full Text] [Related]
10. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
Carbone F; Van den Houte K; Clevers E; Andrews CN; Papathanasopoulos A; Holvoet L; Van Oudenhove L; Caenepeel P; Arts J; Vanuytsel T; Tack J
Am J Gastroenterol; 2019 Aug; 114(8):1265-1274. PubMed ID: 31295161
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications of ghrelin agonists in the treatment of gastroparesis.
Shin A; Wo JM
Curr Gastroenterol Rep; 2015 Feb; 17(2):430. PubMed ID: 25702264
[TBL] [Abstract][Full Text] [Related]
12. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
14. Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis.
Vijayvargiya P; Jameie-Oskooei S; Camilleri M; Chedid V; Erwin PJ; Murad MH
Gut; 2019 May; 68(5):804-813. PubMed ID: 29860241
[TBL] [Abstract][Full Text] [Related]
15. Effects of domperidone on gastric emptying: a crossover study using a continuous real-time 13C breath test (BreathID system).
Sakamoto Y; Kato S; Sekino Y; Sakai E; Uchiyama T; Iida H; Hosono K; Endo H; Fujita K; Koide T; Takahashi H; Yoneda M; Tokoro C; Goto A; Abe Y; Kobayashi N; Kubota K; Maeda S; Nakajima A; Inamori M
Hepatogastroenterology; 2011; 58(106):637-41. PubMed ID: 21661445
[TBL] [Abstract][Full Text] [Related]
16. Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients.
Tatsuta M; Iishi H; Nakaizumi A; Okuda S
Aliment Pharmacol Ther; 1992 Apr; 6(2):221-8. PubMed ID: 1600042
[TBL] [Abstract][Full Text] [Related]
17. Prokinetics in patients with gastroparesis: a systematic analysis.
Sturm A; Holtmann G; Goebell H; Gerken G
Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis.
Hong SW; Chun J; Kim J; Lee J; Lee HJ; Chung H; Cho SJ; Im JP; Kim SG; Kim JS
Gut Liver; 2020 Sep; 14(5):589-600. PubMed ID: 31816671
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
Corinaldesi R; Stanghellini V; Raiti C; Rea E; Salgemini R; Barbara L
Gut; 1987 Mar; 28(3):300-5. PubMed ID: 3552906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
